Icahn Capital 13F holdings, Q4 2009
Holdings as of December 31, 2009 · filings on SEC EDGAR · latest filing →
Icahn Capital disclosed 15 US equity positions worth $2.6bn in its Q4 2009 13F filing. The largest position was MOTOROLA INC at 35.5% of the reported book, followed by BIIB and CIT GROUP INC. Against the Q3 2009 filing, it opened 2 new positions, added to 3 and reduced 1 among the top 15 holdings.
What did Icahn Capital own in Q4 2009? Top 15 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2009 |
|---|---|---|---|---|---|---|---|
| 1 | MOTOROLA INC | 35.5% | $929.6m | 119,790,447 | 0% | held | |
| 2 | BIIB BIOGEN IDEC INC | Healthcare | 26.3% | $688.0m | 12,860,205 | 0% | held |
| 3 | CIT GROUP INC | 10.2% | $268.0m | 9,705,373 | – | new | |
| 4 | GENZYME CORP | 9.0% | $235.2m | 4,798,243 | 231% | added | |
| 5 | YAHOO INC | 7.7% | $201.2m | 11,991,000 | -76% | reduced | |
| 6 | LIONS GATE ENTMNT CORP | 3.7% | $96.4m | 16,592,200 | 0% | held | |
| 7 | TTWO TAKE-TWO INTERACTIVE SOFTWARE INC | Communication Services | 2.6% | $67.3m | 6,700,001 | 234% | added |
| 8 | CYBERONICS INC | 1.6% | $43.1m | 2,107,972 | 0% | held | |
| 9 | FOREST LABS INC | 1.5% | $39.0m | 1,213,120 | 21% | added | |
| 10 | ENZON PHARMACEUTICALS INC | 1.1% | $29.7m | 2,816,861 | 0% | held | |
| 11 | EXEL EXELIXIS INC | Healthcare | 0.7% | $17.4m | 2,357,110 | 0% | held |
| 12 | WENDYS ARBYS GROUP INC | 0.1% | $3.0m | 643,590 | 0% | held | |
| 13 | ADVENTRX PHARMACEUTICALS INC | 0.0% | $1.2m | 3,459,459 | 0% | held | |
| 14 | LIONS GATE ENTMNT CORP | 0.0% | $884.0k | 923,200 | 0% | held | |
| 15 | LIONS GATE ENTMNT CORP | 0.0% | $325.0k | 343,200 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.